GLORY HEALTH (02329) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of RMB324 million, representing a year-on-year decrease of 67.17%. The loss attributable to owners of the company reached RMB225 million, surging 283.88% compared to the same period last year. Basic loss per share stood at 5.07 cents.

According to the announcement, property development revenue for the six months ended June 30, 2025 amounted to RMB183 million, down 76.9% from the corresponding period last year. The decline in revenue during the reporting period was primarily attributed to reduced completion and delivery area in the property development segment, as well as decreased sales.